EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Vaccine-associated axillary lymphadenopathy with a focus on COVID-19 vaccines

Caroline Wilpert iD, Evelyn Wenkel iD, Pascal Andreas Thomas Baltzer, Eva Maria Fallenberg, Heike Preibsch, Stephanie Tina Sauer iD, Katja Siegmann-Luz, Stefanie Weigel, Petra Wunderlich, Daniel Wessling

RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren · 01.03.2025 · 197 (03) · 288-297

DOI: 10.1055/a-2328-7536 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, erschienen am 01.03.2025. Verfasst von Caroline Wilpert und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic and Interventional Radiology, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Ger…. Hauptthemen laut MEDLINE: COVID-19 Vaccines, Lymphadenopathy, COVID-19. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Axillary lymphadenopathy (LA) after COVID-19 vaccination is now known to be a common side effect. In these cases, malignancy cannot always be excluded on the basis of morphological imaging criteria. Narrative review for decision-making regarding control and follow-up intervals for axillary LA according to currently published research. This article provides a practical overview of the management of vaccine-associated LA using image examples and a flowchart and provides recommendations for follow-up intervals. A particular focus is on patients presenting for diagnostic breast imaging. The diagnostic criteria for pathological lymph nodes (LN) are explained. Axillary LA is a common adverse effect after COVID-19 vaccination (0.3–53%). The average duration of LA is more than 100 days. LA is also known to occur after other vaccinations, such as the seasonal influenza vaccine. Systematic studies on this topic are missing. Other causes of LA after vaccination (infections, autoimmune diseases, malignancies) should be considered for the differential diagnosis. If the LA persists for more than 3 months after COVID-19 vaccination, a primarily sonographic follow-up examination is recommended after another 3 months. A minimally invasive biopsy of the LA is recommended if a clinically suspicious LN persists or progresses. In the case of histologically confirmed breast cancer, a core biopsy without a follow-up interval is recommended regardless of the vaccination, as treatment appropriate to the stage should not be influenced by follow-up intervals. For follow-up after breast cancer, the procedure depends on the duration of the LA and the woman’s individual risk of recurrence. Vaccination history should be well documented and taken into account when evaluating suspicious LN. Biopsy of abnormal, persistent, or progressive LNs is recommended. Preoperative staging of breast cancer should not be delayed by follow-up. The risk of false-positive findings is accepted, and the suspicious LNs are histologically examined in a minimally invasive procedure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19 VaccinesLymphadenopathyCOVID-19HumansAxillaFemaleLymph NodesDiagnosis, Differential

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • Department of Diagnostic and Interventional Radiology, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Radiology, Radiologie München, Munich, Germany.
  • Medical Faculty, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Unit of General Radiology and Paediatric Radiology, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria.
  • Diagnostic and Interventional Radiology, TUM, Munich, Germany.
  • Diagnostic and Interventional Radiology, University Hospital Tuebingen, Tuebingen, Germany.

ORCID-Profile: Caroline Wilpert, Evelyn Wenkel, Stephanie Tina Sauer

Zitieren

APA

Wilpert, C., Wenkel, E., Baltzer, P. A. T., Fallenberg, E. M., Preibsch, H., Sauer, S. T., Siegmann-Luz, K., Weigel, S., Wunderlich, P., & Wessling, D. (2025). Vaccine-associated axillary lymphadenopathy with a focus on COVID-19 vaccines. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, 197(03), 288-297. https://doi.org/10.1055/a-2328-7536

Vancouver

Wilpert C, Wenkel E, Baltzer PAT, Fallenberg EM, Preibsch H, Sauer ST, et al. Vaccine-associated axillary lymphadenopathy with a focus on COVID-19 vaccines. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 2025;197(03):288-297. doi:10.1055/a-2328-7536

BibTeX
@article{Wilpert2025,
  author = {Wilpert, Caroline and Wenkel, Evelyn and Baltzer, Pascal Andreas Thomas and Fallenberg, Eva Maria and Preibsch, Heike and Sauer, Stephanie Tina and Siegmann-Luz, Katja and Weigel, Stefanie and Wunderlich, Petra and Wessling, Daniel},
  title = {Vaccine-associated axillary lymphadenopathy with a focus on COVID-19 vaccines},
  journal = {RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren},
  year = {2025},
  volume = {197},
  number = {03},
  pages = {288--297},
  doi = {10.1055/a-2328-7536}
}
Kostenlos starten →